May
20, 2010 --Creation of a Bacterial Cell Controlled by a Chemically
Synthesized Genome
Scientists
have developed the first cell controlled by a synthetic
genome, and now hope to use this method to probe the basic
machinery of life and to engineer bacteria specially designed
to solve environmental or energy problems.
The
study was published online by the journal Science, at the
Science Express website, on Thursday, 20 May. The Science
authors discussed their findings in a Thursday press conference
at the Newseum in Washington, D.C.
|
|
The
research team, led by genetic research pioneer J. Craig Venter,
has already chemically synthesized a bacterial genome, and it
has transplanted the genome of one bacterium to another. Now,
the scientists have put both methods together, to create what
they call a “synthetic cell,” although only its genome is synthetic.
The
research team, led by genetic research pioneer J. Craig Venter,
has already chemically synthesized a bacterial genome, and it
has transplanted the genome of one bacterium to another. Now,
the scientists have put both methods together, to create what
they call a “synthetic cell,” although only its genome is synthetic.
“This
is the first synthetic cell that’s been made, and we call it synthetic
because the cell is totally derived from a synthetic chromosome,
made with four bottles of chemicals on a chemical synthesizer,
starting with information in a computer,” said Venter, the founder,
president, and chairman of the J. Craig Venter Institute. “This
becomes a very powerful tool for trying to design what we want
biology to do. We have a wide range of applications [in mind],”
he said.
For
example, the researchers are planning to design algae that can
capture carbon dioxide and make new hydrocarbons that could go
into refineries. They are also working on ways to speed up vaccine
production. Making new chemicals or food ingredients and cleaning
up water are other possible benefits, according to Venter.
In
the Science study, the researchers synthesized the genome of the
bacterium M. mycoides and added DNA sequences that “watermark”
the genome to distinguish it from a natural one.
Because
current machines can only assemble relatively short strings of
DNA letters at a time, the researchers inserted the shorter sequences
into yeast, whose DNA-repair enzymes linked the strings together.
They then transferred the medium-sized strings into E. coli bacteria
and back into yeast. After three rounds of assembly, the researchers
had produced a genome over a million base pairs long.
The
scientists then transplanted the synthetic M. mycoides genome
into another type of bacteria, Mycoplasm capricolum. The new genome
“booted up” the recipient cells. Although 14 genes were deleted
or disrupted in the transplant bacteria, they still looked like
normal M. mycoides bacteria and produced only M. mycoides proteins,
the authors report.
“This
is an important step we think, both scientifically and philosophically.
It’s certainly changed my views of the definitions of life and
how life works,” Venter said. Acknowledging the ethical discussion
about synthetic biology research, Venter explained that his team
asked for a bioethical review in the late 1990s and has participated
in variety of discussions on the topic.
“I
think this is the first incidence in science where the extensive
bioethical review took place before the experiments were done.
It’s part of an ongoing process that we’ve been driving, trying
to make sure that the science proceeds in an ethical fashion,
that we’re being thoughtful about what we do and looking forward
to the implications to the future,” he said.
Source:
AAAS -- Kathy Wren
Creation
of a Bacterial Cell Controlled by a Chemically Synthesized Genome
-- Daniel G. Gibson1, John I. Glass1, Carole Lartigue1, Vladimir
N. Noskov1, Ray-Yuan Chuang1, Mikkel A. Algire1, Gwynedd A. Benders2,
Michael G. Montague1, Li Ma1, Monzia M. Moodie1, Chuck Merryman1,
Sanjay Vashee1, Radha Krishnakumar1, Nacyra Assad-Garcia1, Cynthia
Andrews-Pfannkoch1, Evgeniya A. Denisova1, Lei Young1, Zhi-Qing
Qi1, Thomas H. Segall-Shapiro1, Christopher H. Calvey1, Prashanth
P. Parmar1, Clyde A. Hutchison III2, Hamilton O. Smith2 and J.
Craig Venter1,2,*
|